Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Astrazeneca Uk Limited patents


Recent patent applications related to Astrazeneca Uk Limited. Astrazeneca Uk Limited is listed as an Agent/Assignee. Note: Astrazeneca Uk Limited may have other listings under different names/spellings. We're not affiliated with Astrazeneca Uk Limited, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Astrazeneca Uk Limited-related inventors


Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one

The present invention relates to a pharmaceutical formulation comprising the drug 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one in a solid dispersion with a matrix polymer that exhibits low hygroscopicity and high softening temperature, such as copovidone. The invention also relates to a daily pharmaceutical dose of the drug provided by such a formulation. ... Astrazeneca Uk Limited

Bilayer tablet formulations

The present invention relates to bilayer tablet formulations comprising metformin extended release (xr) or reduced mass metformin xr formulation as the first layer, an sglt2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with sglt2 activity employing the bilayer tablet formulations.. ... Astrazeneca Uk Limited

Pharmaceutical composition of rosuvastatin calcium

The invention relates to pharmaceutical compositions containing rosuvastatin calcium of formula (i) and processes for their manufacture.. . ... Astrazeneca Uk Limited

Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one

The present invention relates to a pharmaceutical formulation comprising the drug 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one in a solid dispersion with a matrix polymer that exhibits low hygroscopicity and high softening temperature, such as copovidone. The invention also relates to a daily pharmaceutical dose of the drug provided by such a formulation. ... Astrazeneca Uk Limited








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Astrazeneca Uk Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Astrazeneca Uk Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###